Download PDF
Kinder- und Jugendmedizin 2004; 4(02): 44-49
DOI: 10.1055/s-0037-1617810
Impfungen
Schattauer GmbH

Impfungen von Frühgeborenen

Vaccinations of preterm infants
Frank Kowalzik
1   Johannes Gutenberg-Universität Mainz, Kinderklinik und Kinderpoliklinik (Direktor: Univ.-Prof. Dr. med. F. Zepp)
,
Pirmin Habermehl
1   Johannes Gutenberg-Universität Mainz, Kinderklinik und Kinderpoliklinik (Direktor: Univ.-Prof. Dr. med. F. Zepp)
,
Christoph Kampmann
1   Johannes Gutenberg-Universität Mainz, Kinderklinik und Kinderpoliklinik (Direktor: Univ.-Prof. Dr. med. F. Zepp)
,
Markus Knuf
1   Johannes Gutenberg-Universität Mainz, Kinderklinik und Kinderpoliklinik (Direktor: Univ.-Prof. Dr. med. F. Zepp)
› Author Affiliations
Further Information

Publication History

Publication Date:
12 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Die Frage des optimalen Zeitpunkts, um ein frühgeborenes Kind zu impfen, ist letztendlich nicht geklärt. Sicher ist, dass Frühgeborene einem erhöhten Risiko ausgesetzt sind, an einer schweren Infektionskrankheit zu erkranken. Zudem ist bekannt, dass die Ausbildung eines voll funktionsfähigen Immunsystems stark von dem Gestationsalter abhängig ist. Demgegenüber steht das Bestreben, den Kindern durch die Impfung eine wirksame und rechtzeitige Prophylaxe zu ermöglichen, d. h. Frühgeborene möglichst zeitnah nach Geburt zu immunisieren, da die Inzidenz verschiedener Krankheiten, wie z. B. invasiver Hib-Erkrankungen und Keuchhusten, bei Kindern im ersten Lebensjahr am höchsten ist. Diese Arbeit soll die grundlegenden Besonderheiten des sich entwickelnden Immunsystems darstellen und unter Berücksichtigung der empfohlenen Impfungen, eine praxisnahe Umsetzung ermöglichen.

Summary

When is the best time point to vaccinate a preterm infant? In the end this question is not cleared. Preterm infants are at an higher risk to aquire a severe infection. Besides this it is widely known, that the development of a functional immune system depends highly on the gestational age. On the other hand it must be the endeavor, to protect these infants with a effective prophylaxis in time, which means to vaccinate them short after birth, because of the fact, that in infants less than one year the highest incidence of some diseases, such as invasive Hib- and pertussis infections appears. This article demonstrates the main specialities of the developing immune system and should give a practical proposal, on consideration of the recommended schedule.

Schlüsselwörter

Frühgeburt - Impfung - Immunsystem

Keywords

Preterm infant - vaccination - immune system
 

  • Literatur

  • 1 Adenyi-Jones SA, Faden H. et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. Journal of Pediatrics 1992; 120: 686-9.
    CrossrefPubMedGoogle Scholar
  • 2 American Academy of Pediatrics. Report of the Committee on Infectious Diseases. 21st edn. Elk Grove Village, Illinois: The 1988 red book.;
    Google Scholar
  • 3 Belson A, Reif S. et al. Immune response to Hepatitis B virus vaccine in 1 year-old preterm and term infants. Journal of Pediatric Gastroenterology and Nutrition 1996; 23: 252-5.
    CrossrefPubMedGoogle Scholar
  • 4 Bernbaum JC, Daft A. et al. Response of preterm infants to Diphtheria-Tetanus-Pertussis immunizations. Journal of Pediatrics 1985; 107: 184-8.
    CrossrefPubMedGoogle Scholar
  • 5 Bernbaum J, Anolik R. et al. Development of the premature infants host defense system and its relationship to routine immunisation. Clinics in Perionatology 1984; 11: 73-4.
    Google Scholar
  • 6 Björkholm B, Granström M. et al. Influence of high titers of maternal antibody on the serologic response of infants to Diphtheria vaccination at three, five and twelve month of age. Pediatric Infectious Disease Journal 1995; 14: 846-50.
    CrossrefPubMedGoogle Scholar
  • 7 Chawareewong S. Immune response to Hepatitis B vaccine in premature neonates. Southeast Asian Journal Trp Med Public 1991; 22: 39-40.
    Google Scholar
  • 8 Conway S, James J. et al. Immunisation of preterm babies. Journal of Infection 1993; 27: 143-50.
    CrossrefPubMedGoogle Scholar
  • 9 D’Angio CT, Maniscalco W. et al. Immunologic response of extremely premature infants to Tetanus, Haemophilus influenzae and Polio immunizations. Pediatrics 1995; 96: 18-22.
    PubMedGoogle Scholar
  • 10 Del Canho R, Grosheide P. et al. Hepatitis B vaccination and preterm infants. Pediatric Infectious Disease Journal 1993; 12: 407-8.
    CrossrefPubMedGoogle Scholar
  • 11 Deutsche Gesellschaft für pädiatrische Infektiologie. Prophylaxe von bedrohlichen RSV-Erkrankungen durch Palivizumab. Stellungnahme. 2003: 1-6 http://www.dgpi.de/Publikation/PDFs/DGPIsynagisVO%c9S%c9%2005%202003fin.pdf
    PubMedGoogle Scholar
  • 12 Esposito S, Faldella G. et al. Long term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in preterm infants. Vaccine 2002; 20 (23-24) 2928-32.
    CrossrefPubMedGoogle Scholar
  • 13 Fachinformation Synagis. Abbott GmbH; 1999
    Google Scholar
  • 14 Faldella G, Alessandrini R. et al. The preterm infant’s antibody response to a combined Diphtheria, Tetanus, acellular Pertussis and hepatitis B vaccine. Vaccine 1998; 16: 1646-49.
    CrossrefPubMedGoogle Scholar
  • 15 Gerli R, Bertotto A. et al. Activation of cord T lymphocytes. I. Evidence for defective T cell mitogenesis induced through CD2 molecule. Journal of immunology 1989; 142: 2583-9.
    PubMedGoogle Scholar
  • 16 Harvey J, Jones DB. et al. Differential expression of MHC- and macrophage-associated antigens in human and postnatal small intestine. Immunology 1990; 69: 409-15.
    Google Scholar
  • 17 Hitzig WH. Die Entwicklung des Immunsystems beim Menschen. In: Wahn U, Seger R, Wahn V. Pädiatrische Allergologie und Immunologie, 2. Auflage. München: Fischer; 1994
    Google Scholar
  • 18 Hohlfeld P, Forestier F. et al. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mother and fetuses. Pediatric Infectious Disease Journal 1990; 9: 878-81.
    CrossrefPubMedGoogle Scholar
  • 19 Huang F, Lee P. et al. Hepatitis B vaccination in preterm infants. Archives of Disease in Childhood 1997; 77: F135-8.
    CrossrefPubMedGoogle Scholar
  • 20 Joint Committee on Immunisation and Vaccination. Immunisation against infectious disease. London: HM Stationery Office; 1988
    Google Scholar
  • 21 Khalak R, Pichichero M. et al. Three year follow-up of vaccine response in extremely preterm infants. Pediatrics 1998; 101: 597-603.
    CrossrefPubMedGoogle Scholar
  • 22 Kim SC, Chung EK. et al. Immunogenicity of Hepatitis B vaccine in preterm infants. Pediatrics 1997; 99: 534-6.
    CrossrefPubMedGoogle Scholar
  • 23 Kristensen K, Gyhrs A. et al. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatric Infectious Disease Journal 1996; 15: 525-9.
    CrossrefPubMedGoogle Scholar
  • 24 Kumar A, Jauhari P. et al. Quantitation of T cells in venous blood of healthy neonates. Indian Journal of Pediatrics 1994; 61: 711-4.
    CrossrefPubMedGoogle Scholar
  • 25 Lau Y, Tam A. et al. Response of preterm infants to Hepatitis B vaccine. Journal of Pediatrics 1992; 121: 962-5.
    CrossrefPubMedGoogle Scholar
  • 26 Linder N, Vishne TH. et al. Heapatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols. Infection 2002; 30 (03) 136-9.
    CrossrefPubMedGoogle Scholar
  • 27 Munoz A, Salvador A. et al. Antibody response of low birth weight infants to Haemophilus influenzae type b Polyribosylribitol-phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995; 96: 216-9.
    PubMedGoogle Scholar
  • 28 Oliver AM, Sewell H. et al. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, DQ) in human fetal adrenal, pancreas, thyroid and gut. Transplant Proc 1989; 21: 651-2.
    PubMedGoogle Scholar
  • 29 Pullan CR, Hull D. Routine immunisation of preterm infants. Archives of Disease in Childhood 1989; 64: 1438-41.
    CrossrefPubMedGoogle Scholar
  • 30 Ramsay ME, Miller E. et al. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Archives of Disease in Childhood 1995; 72: 230-2.
    CrossrefPubMedGoogle Scholar
  • 31 Reen JR. Activation and functional capacity of human neonatal CD4 T-cells. Vaccine 1998; 16 (14-15) 1401-8.
    CrossrefPubMedGoogle Scholar
  • 32 Remington JS, Klein JO. Infectious Diseases of the Fetus and Newborn Infant. 4. ed.. Philadelphia: WB Saunders; 1995
    Google Scholar
  • 33 Schloesser RL, Fischer D. et al. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999; 103 (05) e60.
    CrossrefPubMedGoogle Scholar
  • 34 Shinefield H, Black S. et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pedaitr Inf Dis J 2002; 21 (03) 182-6.
    Google Scholar
  • 35 Siegrist CA. Vaccination strategies for children with specific medical conditions: A paediatrician’s viewpoint. European Journal of Pediatrics 1997; 156: 899-904.
    CrossrefPubMedGoogle Scholar
  • 36 Smolen P, Bland R. et al. Antibody response to oral Polio vaccine in premature infants. Journal of Pediatrics 1983; 103: 917-9.
    CrossrefPubMedGoogle Scholar
  • 37 Washburn LK, O’Shea TM. et al. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. Journal of Pediatrics 1993; 123: 791-4.
    CrossrefPubMedGoogle Scholar
  • 38 Zepp F, Schmitt HJ. et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus type b – PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. European Journal of Pediatrics 1997; 156: 18-24.
    CrossrefPubMedGoogle Scholar
  • 39 Zepp F, Knuf M. et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infection and Immunity 1996; 64: 4078-84.
    PubMedGoogle Scholar